ATMPs Put EU Cross-Border Healthcare On The Map
New Recommendations Aim To Improve Cross-Border Healthcare
Executive Summary
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
You may also be interested in...
EFPIA On How To Make Cross-Country Collaborations Work
Cross-country collaboration on pricing and reimbursement will only work if they are based on certain overarching principles, says the European Federation of Pharmaceutical Industries and Associations.
Bluebird Bio Withdraws Zynteglo From Germany Over Pricing
After arbitrators set an unpalatably low price for the company, bluebird is withdrawing its Zyntgelo gene therapy from Germany. The company also announced it would be restructuring its workforce, with job losses expected.
UK: RWD At Center Of NICE Five-Year Strategy
NICE will develop standards for using real world data as part of a new five-year strategic plan that the UK health technology assessment body hopes will make it a leader in the use of research and data.